nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A5—Artemether—malaria	0.0583	0.0758	CbGbCtD
Temsirolimus—CYP3A7—Quinine—malaria	0.0471	0.0612	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Quinine—malaria	0.0471	0.0612	CbGbCtD
Temsirolimus—CYP3A4—Clindamycin—malaria	0.0465	0.0605	CbGbCtD
Temsirolimus—CYP2D6—Pyrimethamine—malaria	0.042	0.0546	CbGbCtD
Temsirolimus—CYP3A7—Quinidine—malaria	0.0414	0.0538	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Quinidine—malaria	0.0414	0.0538	CbGbCtD
Temsirolimus—CYP2D6—Artemether—malaria	0.0357	0.0465	CbGbCtD
Temsirolimus—CYP3A7—Dapsone—malaria	0.0357	0.0464	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dapsone—malaria	0.0357	0.0464	CbGbCtD
Temsirolimus—CYP3A5—Quinine—malaria	0.0353	0.0459	CbGbCtD
Temsirolimus—CYP2D6—Proguanil—malaria	0.0336	0.0437	CbGbCtD
Temsirolimus—CYP2D6—Quinidine barbiturate—malaria	0.0319	0.0414	CbGbCtD
Temsirolimus—CYP3A5—Dapsone—malaria	0.0268	0.0348	CbGbCtD
Temsirolimus—CYP3A4—Sulfadiazine—malaria	0.0267	0.0347	CbGbCtD
Temsirolimus—ABCB1—Quinine—malaria	0.023	0.0299	CbGbCtD
Temsirolimus—CYP3A4—Artemether—malaria	0.0227	0.0295	CbGbCtD
Temsirolimus—CYP2D6—Quinine—malaria	0.0217	0.0281	CbGbCtD
Temsirolimus—CYP3A4—Proguanil—malaria	0.0214	0.0278	CbGbCtD
Temsirolimus—CYP3A4—Doxycycline—malaria	0.0203	0.0263	CbGbCtD
Temsirolimus—ABCB1—Quinidine—malaria	0.0202	0.0263	CbGbCtD
Temsirolimus—CYP2D6—Quinidine—malaria	0.019	0.0247	CbGbCtD
Temsirolimus—CYP3A4—Quinine—malaria	0.0138	0.0179	CbGbCtD
Temsirolimus—CYP3A4—Quinidine—malaria	0.0121	0.0157	CbGbCtD
Temsirolimus—CYP3A4—Dapsone—malaria	0.0104	0.0136	CbGbCtD
Temsirolimus—MTOR—blood plasma—malaria	0.00519	0.0888	CbGeAlD
Temsirolimus—FKBP1A—blood plasma—malaria	0.00466	0.0798	CbGeAlD
Temsirolimus—MTOR—hematopoietic system—malaria	0.00287	0.0491	CbGeAlD
Temsirolimus—FKBP1A—hematopoietic system—malaria	0.00258	0.0442	CbGeAlD
Temsirolimus—MTOR—kidney—malaria	0.00235	0.0402	CbGeAlD
Temsirolimus—FKBP1A—kidney—malaria	0.00211	0.0362	CbGeAlD
Temsirolimus—CYP3A5—blood plasma—malaria	0.00203	0.0348	CbGeAlD
Temsirolimus—MTOR—digestive system—malaria	0.00199	0.0341	CbGeAlD
Temsirolimus—MTOR—blood—malaria	0.0019	0.0325	CbGeAlD
Temsirolimus—MTOR—bone marrow—malaria	0.00184	0.0315	CbGeAlD
Temsirolimus—FKBP1A—digestive system—malaria	0.00179	0.0307	CbGeAlD
Temsirolimus—FKBP1A—blood—malaria	0.00171	0.0293	CbGeAlD
Temsirolimus—FKBP1A—bone marrow—malaria	0.00165	0.0283	CbGeAlD
Temsirolimus—CYP3A7—liver—malaria	0.00165	0.0283	CbGeAlD
Temsirolimus—CYP3A4—blood plasma—malaria	0.00152	0.0261	CbGeAlD
Temsirolimus—CYP2D6—blood plasma—malaria	0.0015	0.0257	CbGeAlD
Temsirolimus—MTOR—liver—malaria	0.00149	0.0254	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—malaria	0.00141	0.0241	CbGeAlD
Temsirolimus—FKBP1A—liver—malaria	0.00134	0.0229	CbGeAlD
Temsirolimus—MTOR—brain—malaria	0.00118	0.0202	CbGeAlD
Temsirolimus—CYP3A5—hematopoietic system—malaria	0.00112	0.0192	CbGeAlD
Temsirolimus—ABCB1—blood plasma—malaria	0.00108	0.0185	CbGeAlD
Temsirolimus—FKBP1A—brain—malaria	0.00106	0.0182	CbGeAlD
Temsirolimus—CYP3A5—kidney—malaria	0.00092	0.0158	CbGeAlD
Temsirolimus—CYP3A4—hematopoietic system—malaria	0.000843	0.0144	CbGeAlD
Temsirolimus—CYP2D6—hematopoietic system—malaria	0.000829	0.0142	CbGeAlD
Temsirolimus—CYP3A5—digestive system—malaria	0.000781	0.0134	CbGeAlD
Temsirolimus—CYP3A5—blood—malaria	0.000744	0.0127	CbGeAlD
Temsirolimus—MTOR—TSLP Signaling Pathway—CISH—malaria	0.000693	0.0445	CbGpPWpGaD
Temsirolimus—CYP3A4—kidney—malaria	0.000691	0.0118	CbGeAlD
Temsirolimus—CYP2D6—kidney—malaria	0.00068	0.0116	CbGeAlD
Temsirolimus—Chills—Sulfadiazine—malaria	0.000635	0.00406	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Proguanil—malaria	0.000619	0.00396	CcSEcCtD
Temsirolimus—Vomiting—Pyrimethamine—malaria	0.000618	0.00395	CcSEcCtD
Temsirolimus—Dysuria—Clindamycin—malaria	0.000615	0.00393	CcSEcCtD
Temsirolimus—Neutropenia—Clindamycin—malaria	0.000615	0.00393	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Clindamycin—malaria	0.000612	0.00391	CcSEcCtD
Temsirolimus—Neutropenia—Quinidine—malaria	0.000604	0.00386	CcSEcCtD
Temsirolimus—Neutropenia—Quinine—malaria	0.000604	0.00386	CcSEcCtD
Temsirolimus—Body temperature increased—Proguanil—malaria	0.000599	0.00383	CcSEcCtD
Temsirolimus—Abdominal pain—Proguanil—malaria	0.000599	0.00383	CcSEcCtD
Temsirolimus—ABCB1—hematopoietic system—malaria	0.000597	0.0102	CbGeAlD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000596	0.0383	CbGpPWpGaD
Temsirolimus—CYP3A4—digestive system—malaria	0.000586	0.01	CbGeAlD
Temsirolimus—Abdominal distension—Pentoxifylline—malaria	0.000585	0.00374	CcSEcCtD
Temsirolimus—CYP3A5—liver—malaria	0.000582	0.00996	CbGeAlD
Temsirolimus—Stevens-Johnson syndrome—Clindamycin—malaria	0.000582	0.00372	CcSEcCtD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000579	0.0372	CbGpPWpGaD
Temsirolimus—CYP2D6—digestive system—malaria	0.000577	0.00987	CbGeAlD
Temsirolimus—Stevens-Johnson syndrome—Quinine—malaria	0.000571	0.00365	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Quinidine—malaria	0.000571	0.00365	CcSEcCtD
Temsirolimus—Urinary tract infection—Clindamycin—malaria	0.00057	0.00365	CcSEcCtD
Temsirolimus—Sinusitis—Dapsone—malaria	0.000569	0.00364	CcSEcCtD
Temsirolimus—Renal failure—Quinidine—malaria	0.000566	0.00362	CcSEcCtD
Temsirolimus—Renal failure—Quinine—malaria	0.000566	0.00362	CcSEcCtD
Temsirolimus—CYP3A4—blood—malaria	0.000558	0.00956	CbGeAlD
Temsirolimus—Epistaxis—Clindamycin—malaria	0.000553	0.00354	CcSEcCtD
Temsirolimus—Leukopenia—Sulfadiazine—malaria	0.000551	0.00352	CcSEcCtD
Temsirolimus—CYP2D6—blood—malaria	0.000549	0.00941	CbGeAlD
Temsirolimus—Neutropenia—Quinidine barbiturate—malaria	0.000545	0.00348	CcSEcCtD
Temsirolimus—Pharyngitis—Dapsone—malaria	0.00054	0.00345	CcSEcCtD
Temsirolimus—Convulsion—Sulfadiazine—malaria	0.000534	0.00341	CcSEcCtD
Temsirolimus—Arthralgia—Sulfadiazine—malaria	0.000524	0.00335	CcSEcCtD
Temsirolimus—Infestation—Pentoxifylline—malaria	0.000519	0.00331	CcSEcCtD
Temsirolimus—Infestation NOS—Pentoxifylline—malaria	0.000519	0.00331	CcSEcCtD
Temsirolimus—Diarrhoea—Proguanil—malaria	0.000518	0.00331	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000515	0.00329	CcSEcCtD
Temsirolimus—Renal failure—Quinidine barbiturate—malaria	0.000511	0.00326	CcSEcCtD
Temsirolimus—Urinary tract disorder—Quinidine—malaria	0.00051	0.00326	CcSEcCtD
Temsirolimus—Urinary tract disorder—Quinine—malaria	0.00051	0.00326	CcSEcCtD
Temsirolimus—Urethral disorder—Quinine—malaria	0.000507	0.00324	CcSEcCtD
Temsirolimus—Urethral disorder—Quinidine—malaria	0.000507	0.00324	CcSEcCtD
Temsirolimus—Conjunctivitis—Pentoxifylline—malaria	0.000504	0.00322	CcSEcCtD
Temsirolimus—Anaphylactic shock—Sulfadiazine—malaria	0.000503	0.00321	CcSEcCtD
Temsirolimus—Erythema multiforme—Clindamycin—malaria	0.000498	0.00318	CcSEcCtD
Temsirolimus—Thrombocytopenia—Sulfadiazine—malaria	0.000492	0.00315	CcSEcCtD
Temsirolimus—Epistaxis—Pentoxifylline—malaria	0.000489	0.00313	CcSEcCtD
Temsirolimus—ABCB1—kidney—malaria	0.000489	0.00837	CbGeAlD
Temsirolimus—Erythema multiforme—Quinidine—malaria	0.000489	0.00312	CcSEcCtD
Temsirolimus—Erythema multiforme—Quinine—malaria	0.000489	0.00312	CcSEcCtD
Temsirolimus—Eye disorder—Quinidine—malaria	0.000483	0.00309	CcSEcCtD
Temsirolimus—Eye disorder—Quinine—malaria	0.000483	0.00309	CcSEcCtD
Temsirolimus—Vomiting—Proguanil—malaria	0.000481	0.00308	CcSEcCtD
Temsirolimus—Cardiac disorder—Quinidine—malaria	0.00048	0.00307	CcSEcCtD
Temsirolimus—Cardiac disorder—Quinine—malaria	0.00048	0.00307	CcSEcCtD
Temsirolimus—Anorexia—Sulfadiazine—malaria	0.000479	0.00306	CcSEcCtD
Temsirolimus—Rash—Proguanil—malaria	0.000477	0.00305	CcSEcCtD
Temsirolimus—Dermatitis—Proguanil—malaria	0.000477	0.00305	CcSEcCtD
Temsirolimus—MTOR—Leptin signaling pathway—CISH—malaria	0.000477	0.0306	CbGpPWpGaD
Temsirolimus—Headache—Proguanil—malaria	0.000474	0.00303	CcSEcCtD
Temsirolimus—Erythema—Dapsone—malaria	0.000474	0.00303	CcSEcCtD
Temsirolimus—Immune system disorder—Quinidine—malaria	0.000467	0.00298	CcSEcCtD
Temsirolimus—Immune system disorder—Quinine—malaria	0.000467	0.00298	CcSEcCtD
Temsirolimus—Mediastinal disorder—Quinidine—malaria	0.000466	0.00298	CcSEcCtD
Temsirolimus—Mediastinal disorder—Quinine—malaria	0.000466	0.00298	CcSEcCtD
Temsirolimus—Chills—Quinidine—malaria	0.000464	0.00296	CcSEcCtD
Temsirolimus—Chills—Quinine—malaria	0.000464	0.00296	CcSEcCtD
Temsirolimus—Urinary tract disorder—Quinidine barbiturate—malaria	0.000461	0.00294	CcSEcCtD
Temsirolimus—Erythema—Clindamycin—malaria	0.000459	0.00293	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000458	0.00293	CcSEcCtD
Temsirolimus—Urethral disorder—Quinidine barbiturate—malaria	0.000457	0.00292	CcSEcCtD
Temsirolimus—Insomnia—Sulfadiazine—malaria	0.000455	0.00291	CcSEcCtD
Temsirolimus—Mental disorder—Quinine—malaria	0.000453	0.00289	CcSEcCtD
Temsirolimus—Mental disorder—Quinidine—malaria	0.000453	0.00289	CcSEcCtD
Temsirolimus—Erythema—Quinidine—malaria	0.00045	0.00288	CcSEcCtD
Temsirolimus—Erythema—Quinine—malaria	0.00045	0.00288	CcSEcCtD
Temsirolimus—Malnutrition—Quinidine—malaria	0.00045	0.00288	CcSEcCtD
Temsirolimus—Malnutrition—Quinine—malaria	0.00045	0.00288	CcSEcCtD
Temsirolimus—Nausea—Proguanil—malaria	0.00045	0.00287	CcSEcCtD
Temsirolimus—Dysgeusia—Clindamycin—malaria	0.000449	0.00287	CcSEcCtD
Temsirolimus—Back pain—Clindamycin—malaria	0.000444	0.00284	CcSEcCtD
Temsirolimus—Erythema multiforme—Quinidine barbiturate—malaria	0.000441	0.00282	CcSEcCtD
Temsirolimus—Decreased appetite—Sulfadiazine—malaria	0.000437	0.00279	CcSEcCtD
Temsirolimus—CYP3A4—liver—malaria	0.000437	0.00748	CbGeAlD
Temsirolimus—Eye disorder—Quinidine barbiturate—malaria	0.000436	0.00279	CcSEcCtD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—CISH—malaria	0.000435	0.028	CbGpPWpGaD
Temsirolimus—Gastrointestinal disorder—Sulfadiazine—malaria	0.000434	0.00277	CcSEcCtD
Temsirolimus—Cardiac disorder—Quinidine barbiturate—malaria	0.000433	0.00277	CcSEcCtD
Temsirolimus—CYP2D6—liver—malaria	0.00043	0.00736	CbGeAlD
Temsirolimus—Anaemia—Clindamycin—malaria	0.000424	0.00271	CcSEcCtD
Temsirolimus—Immune system disorder—Quinidine barbiturate—malaria	0.000421	0.00269	CcSEcCtD
Temsirolimus—Immune system disorder—Pentoxifylline—malaria	0.00042	0.00269	CcSEcCtD
Temsirolimus—Mediastinal disorder—Quinidine barbiturate—malaria	0.00042	0.00269	CcSEcCtD
Temsirolimus—Chills—Quinidine barbiturate—malaria	0.000418	0.00267	CcSEcCtD
Temsirolimus—ABCB1—digestive system—malaria	0.000415	0.0071	CbGeAlD
Temsirolimus—Cough—Dapsone—malaria	0.000414	0.00264	CcSEcCtD
Temsirolimus—Angioedema—Quinidine—malaria	0.000411	0.00263	CcSEcCtD
Temsirolimus—Angioedema—Quinine—malaria	0.000411	0.00263	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Sulfadiazine—malaria	0.000411	0.00263	CcSEcCtD
Temsirolimus—Leukopenia—Clindamycin—malaria	0.00041	0.00262	CcSEcCtD
Temsirolimus—Mental disorder—Quinidine barbiturate—malaria	0.000409	0.00261	CcSEcCtD
Temsirolimus—Malnutrition—Quinidine barbiturate—malaria	0.000406	0.0026	CcSEcCtD
Temsirolimus—Erythema—Quinidine barbiturate—malaria	0.000406	0.0026	CcSEcCtD
Temsirolimus—Erythema—Pentoxifylline—malaria	0.000405	0.00259	CcSEcCtD
Temsirolimus—Leukopenia—Quinine—malaria	0.000403	0.00257	CcSEcCtD
Temsirolimus—Leukopenia—Quinidine—malaria	0.000403	0.00257	CcSEcCtD
Temsirolimus—Abdominal pain—Sulfadiazine—malaria	0.000397	0.00254	CcSEcCtD
Temsirolimus—Body temperature increased—Sulfadiazine—malaria	0.000397	0.00254	CcSEcCtD
Temsirolimus—Dysgeusia—Pentoxifylline—malaria	0.000397	0.00254	CcSEcCtD
Temsirolimus—Hypertension—Clindamycin—malaria	0.000396	0.00253	CcSEcCtD
Temsirolimus—ABCB1—blood—malaria	0.000395	0.00677	CbGeAlD
Temsirolimus—Back pain—Pentoxifylline—malaria	0.000392	0.00251	CcSEcCtD
Temsirolimus—Convulsion—Quinidine—malaria	0.00039	0.00249	CcSEcCtD
Temsirolimus—Convulsion—Quinine—malaria	0.00039	0.00249	CcSEcCtD
Temsirolimus—Chest pain—Quinine—malaria	0.000383	0.00245	CcSEcCtD
Temsirolimus—Myalgia—Quinidine—malaria	0.000383	0.00245	CcSEcCtD
Temsirolimus—Myalgia—Quinine—malaria	0.000383	0.00245	CcSEcCtD
Temsirolimus—Chest pain—Quinidine—malaria	0.000383	0.00245	CcSEcCtD
Temsirolimus—ABCB1—bone marrow—malaria	0.000382	0.00655	CbGeAlD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00038	0.00243	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00038	0.00243	CcSEcCtD
Temsirolimus—Anaemia—Pentoxifylline—malaria	0.000375	0.00239	CcSEcCtD
Temsirolimus—Anaphylactic shock—Clindamycin—malaria	0.000374	0.00239	CcSEcCtD
Temsirolimus—Angioedema—Quinidine barbiturate—malaria	0.000371	0.00237	CcSEcCtD
Temsirolimus—Angioedema—Pentoxifylline—malaria	0.00037	0.00237	CcSEcCtD
Temsirolimus—Hypersensitivity—Sulfadiazine—malaria	0.00037	0.00237	CcSEcCtD
Temsirolimus—Oedema—Quinine—malaria	0.000367	0.00235	CcSEcCtD
Temsirolimus—Oedema—Quinidine—malaria	0.000367	0.00235	CcSEcCtD
Temsirolimus—Thrombocytopenia—Clindamycin—malaria	0.000366	0.00234	CcSEcCtD
Temsirolimus—Leukopenia—Quinidine barbiturate—malaria	0.000363	0.00232	CcSEcCtD
Temsirolimus—Leukopenia—Pentoxifylline—malaria	0.000363	0.00232	CcSEcCtD
Temsirolimus—Nervous system disorder—Quinidine—malaria	0.00036	0.0023	CcSEcCtD
Temsirolimus—Nervous system disorder—Quinine—malaria	0.00036	0.0023	CcSEcCtD
Temsirolimus—Thrombocytopenia—Quinidine—malaria	0.000359	0.0023	CcSEcCtD
Temsirolimus—Thrombocytopenia—Quinine—malaria	0.000359	0.0023	CcSEcCtD
Temsirolimus—Skin disorder—Quinine—malaria	0.000357	0.00228	CcSEcCtD
Temsirolimus—Skin disorder—Quinidine—malaria	0.000357	0.00228	CcSEcCtD
Temsirolimus—Pruritus—Sulfadiazine—malaria	0.000356	0.00227	CcSEcCtD
Temsirolimus—Convulsion—Quinidine barbiturate—malaria	0.000352	0.00225	CcSEcCtD
Temsirolimus—Convulsion—Pentoxifylline—malaria	0.000351	0.00224	CcSEcCtD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.00035	0.0225	CbGpPWpGaD
Temsirolimus—Anorexia—Quinine—malaria	0.00035	0.00224	CcSEcCtD
Temsirolimus—Anorexia—Quinidine—malaria	0.00035	0.00224	CcSEcCtD
Temsirolimus—Insomnia—Dapsone—malaria	0.00035	0.00224	CcSEcCtD
Temsirolimus—Hypertension—Pentoxifylline—malaria	0.00035	0.00224	CcSEcCtD
Temsirolimus—Arthralgia—Quinidine barbiturate—malaria	0.000346	0.00221	CcSEcCtD
Temsirolimus—Myalgia—Quinidine barbiturate—malaria	0.000346	0.00221	CcSEcCtD
Temsirolimus—Chest pain—Quinidine barbiturate—malaria	0.000346	0.00221	CcSEcCtD
Temsirolimus—Chest pain—Pentoxifylline—malaria	0.000345	0.00221	CcSEcCtD
Temsirolimus—Myalgia—Pentoxifylline—malaria	0.000345	0.00221	CcSEcCtD
Temsirolimus—Anxiety—Quinidine barbiturate—malaria	0.000344	0.0022	CcSEcCtD
Temsirolimus—Diarrhoea—Sulfadiazine—malaria	0.000344	0.0022	CcSEcCtD
Temsirolimus—Anxiety—Pentoxifylline—malaria	0.000344	0.0022	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000343	0.00219	CcSEcCtD
Temsirolimus—MTOR—PI3K Cascade—TLR9—malaria	0.000343	0.022	CbGpPWpGaD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000343	0.00219	CcSEcCtD
Temsirolimus—CYP2D6—brain—malaria	0.000341	0.00584	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Quinine—malaria	0.000334	0.00214	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Quinidine—malaria	0.000334	0.00214	CcSEcCtD
Temsirolimus—Dyspnoea—Clindamycin—malaria	0.000334	0.00213	CcSEcCtD
Temsirolimus—Oedema—Quinidine barbiturate—malaria	0.000331	0.00212	CcSEcCtD
Temsirolimus—Anaphylactic shock—Pentoxifylline—malaria	0.000331	0.00211	CcSEcCtD
Temsirolimus—Oedema—Pentoxifylline—malaria	0.000331	0.00211	CcSEcCtD
Temsirolimus—Infection—Pentoxifylline—malaria	0.000329	0.0021	CcSEcCtD
Temsirolimus—Dyspnoea—Quinine—malaria	0.000327	0.00209	CcSEcCtD
Temsirolimus—Dyspnoea—Quinidine—malaria	0.000327	0.00209	CcSEcCtD
Temsirolimus—Nervous system disorder—Quinidine barbiturate—malaria	0.000325	0.00208	CcSEcCtD
Temsirolimus—Thrombocytopenia—Quinidine barbiturate—malaria	0.000324	0.00207	CcSEcCtD
Temsirolimus—Thrombocytopenia—Pentoxifylline—malaria	0.000324	0.00207	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Clindamycin—malaria	0.000323	0.00207	CcSEcCtD
Temsirolimus—Fatigue—Clindamycin—malaria	0.000323	0.00206	CcSEcCtD
Temsirolimus—Skin disorder—Quinidine barbiturate—malaria	0.000322	0.00206	CcSEcCtD
Temsirolimus—Skin disorder—Pentoxifylline—malaria	0.000321	0.00205	CcSEcCtD
Temsirolimus—Constipation—Clindamycin—malaria	0.00032	0.00205	CcSEcCtD
Temsirolimus—Pain—Clindamycin—malaria	0.00032	0.00205	CcSEcCtD
Temsirolimus—Vomiting—Sulfadiazine—malaria	0.00032	0.00204	CcSEcCtD
Temsirolimus—Decreased appetite—Quinidine—malaria	0.000319	0.00204	CcSEcCtD
Temsirolimus—Decreased appetite—Quinine—malaria	0.000319	0.00204	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Quinidine—malaria	0.000317	0.00203	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Quinine—malaria	0.000317	0.00203	CcSEcCtD
Temsirolimus—Rash—Sulfadiazine—malaria	0.000317	0.00203	CcSEcCtD
Temsirolimus—Dermatitis—Sulfadiazine—malaria	0.000317	0.00202	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dapsone—malaria	0.000316	0.00202	CcSEcCtD
Temsirolimus—Anorexia—Quinidine barbiturate—malaria	0.000316	0.00202	CcSEcCtD
Temsirolimus—Anorexia—Pentoxifylline—malaria	0.000315	0.00202	CcSEcCtD
Temsirolimus—Headache—Sulfadiazine—malaria	0.000315	0.00201	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—FCGR2A—malaria	0.000314	0.0202	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000311	0.02	CbGpPWpGaD
Temsirolimus—ABCB1—liver—malaria	0.000309	0.00529	CbGeAlD
Temsirolimus—Gastrointestinal pain—Clindamycin—malaria	0.000306	0.00196	CcSEcCtD
Temsirolimus—Abdominal pain—Dapsone—malaria	0.000306	0.00196	CcSEcCtD
Temsirolimus—Body temperature increased—Dapsone—malaria	0.000306	0.00196	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000302	0.00193	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000301	0.00193	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Quinine—malaria	0.0003	0.00192	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Quinidine—malaria	0.0003	0.00192	CcSEcCtD
Temsirolimus—Insomnia—Pentoxifylline—malaria	0.000299	0.00191	CcSEcCtD
Temsirolimus—Nausea—Sulfadiazine—malaria	0.000299	0.00191	CcSEcCtD
Temsirolimus—Abdominal pain—Clindamycin—malaria	0.000296	0.00189	CcSEcCtD
Temsirolimus—Body temperature increased—Clindamycin—malaria	0.000296	0.00189	CcSEcCtD
Temsirolimus—Dyspnoea—Quinidine barbiturate—malaria	0.000295	0.00189	CcSEcCtD
Temsirolimus—Dyspnoea—Pentoxifylline—malaria	0.000295	0.00188	CcSEcCtD
Temsirolimus—Somnolence—Quinidine barbiturate—malaria	0.000295	0.00188	CcSEcCtD
Temsirolimus—Somnolence—Pentoxifylline—malaria	0.000294	0.00188	CcSEcCtD
Temsirolimus—Abdominal pain—Quinine—malaria	0.00029	0.00186	CcSEcCtD
Temsirolimus—Body temperature increased—Quinine—malaria	0.00029	0.00186	CcSEcCtD
Temsirolimus—Abdominal pain—Quinidine—malaria	0.00029	0.00186	CcSEcCtD
Temsirolimus—Body temperature increased—Quinidine—malaria	0.00029	0.00186	CcSEcCtD
Temsirolimus—Decreased appetite—Quinidine barbiturate—malaria	0.000288	0.00184	CcSEcCtD
Temsirolimus—Decreased appetite—Pentoxifylline—malaria	0.000288	0.00184	CcSEcCtD
Temsirolimus—MTOR—IRS-mediated signalling—TLR9—malaria	0.000287	0.0184	CbGpPWpGaD
Temsirolimus—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000286	0.00183	CcSEcCtD
Temsirolimus—Constipation—Quinidine barbiturate—malaria	0.000283	0.00181	CcSEcCtD
Temsirolimus—Pain—Quinidine barbiturate—malaria	0.000283	0.00181	CcSEcCtD
Temsirolimus—Constipation—Pentoxifylline—malaria	0.000283	0.00181	CcSEcCtD
Temsirolimus—MTOR—IRS-related events—TLR9—malaria	0.000279	0.0179	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—TLR9—malaria	0.000277	0.0178	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Clindamycin—malaria	0.000276	0.00176	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000271	0.00173	CcSEcCtD
Temsirolimus—Hypersensitivity—Quinine—malaria	0.00027	0.00173	CcSEcCtD
Temsirolimus—Hypersensitivity—Quinidine—malaria	0.00027	0.00173	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Pentoxifylline—malaria	0.00027	0.00173	CcSEcCtD
Temsirolimus—MTOR—IGF1R signaling cascade—TLR9—malaria	0.000269	0.0173	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—TLR9—malaria	0.000269	0.0173	CbGpPWpGaD
Temsirolimus—Asthenia—Clindamycin—malaria	0.000269	0.00172	CcSEcCtD
Temsirolimus—Pruritus—Clindamycin—malaria	0.000265	0.00169	CcSEcCtD
Temsirolimus—Asthenia—Quinidine—malaria	0.000263	0.00168	CcSEcCtD
Temsirolimus—Asthenia—Quinine—malaria	0.000263	0.00168	CcSEcCtD
Temsirolimus—Body temperature increased—Quinidine barbiturate—malaria	0.000262	0.00167	CcSEcCtD
Temsirolimus—Abdominal pain—Quinidine barbiturate—malaria	0.000262	0.00167	CcSEcCtD
Temsirolimus—Abdominal pain—Pentoxifylline—malaria	0.000261	0.00167	CcSEcCtD
Temsirolimus—Body temperature increased—Pentoxifylline—malaria	0.000261	0.00167	CcSEcCtD
Temsirolimus—Pruritus—Quinine—malaria	0.00026	0.00166	CcSEcCtD
Temsirolimus—Pruritus—Quinidine—malaria	0.00026	0.00166	CcSEcCtD
Temsirolimus—MTOR—IL12-mediated signaling events—IL12B—malaria	0.000256	0.0165	CbGpPWpGaD
Temsirolimus—Diarrhoea—Clindamycin—malaria	0.000256	0.00164	CcSEcCtD
Temsirolimus—Diarrhoea—Quinine—malaria	0.000251	0.00161	CcSEcCtD
Temsirolimus—Diarrhoea—Quinidine—malaria	0.000251	0.00161	CcSEcCtD
Temsirolimus—MTOR—SREBP signalling—SCARB1—malaria	0.000249	0.016	CbGpPWpGaD
Temsirolimus—Dizziness—Clindamycin—malaria	0.000247	0.00158	CcSEcCtD
Temsirolimus—Vomiting—Dapsone—malaria	0.000246	0.00157	CcSEcCtD
Temsirolimus—ABCB1—brain—malaria	0.000245	0.0042	CbGeAlD
Temsirolimus—Hypersensitivity—Quinidine barbiturate—malaria	0.000244	0.00156	CcSEcCtD
Temsirolimus—Hypersensitivity—Pentoxifylline—malaria	0.000244	0.00156	CcSEcCtD
Temsirolimus—Dizziness—Quinidine—malaria	0.000243	0.00155	CcSEcCtD
Temsirolimus—Dizziness—Quinine—malaria	0.000243	0.00155	CcSEcCtD
Temsirolimus—Headache—Dapsone—malaria	0.000242	0.00155	CcSEcCtD
Temsirolimus—Vomiting—Clindamycin—malaria	0.000238	0.00152	CcSEcCtD
Temsirolimus—Asthenia—Quinidine barbiturate—malaria	0.000238	0.00152	CcSEcCtD
Temsirolimus—Asthenia—Pentoxifylline—malaria	0.000237	0.00152	CcSEcCtD
Temsirolimus—Rash—Clindamycin—malaria	0.000236	0.00151	CcSEcCtD
Temsirolimus—Dermatitis—Clindamycin—malaria	0.000236	0.00151	CcSEcCtD
Temsirolimus—Headache—Clindamycin—malaria	0.000234	0.0015	CcSEcCtD
Temsirolimus—Pruritus—Quinidine barbiturate—malaria	0.000234	0.0015	CcSEcCtD
Temsirolimus—Pruritus—Pentoxifylline—malaria	0.000234	0.0015	CcSEcCtD
Temsirolimus—Vomiting—Quinidine—malaria	0.000233	0.00149	CcSEcCtD
Temsirolimus—Vomiting—Quinine—malaria	0.000233	0.00149	CcSEcCtD
Temsirolimus—Rash—Quinine—malaria	0.000231	0.00148	CcSEcCtD
Temsirolimus—Rash—Quinidine—malaria	0.000231	0.00148	CcSEcCtD
Temsirolimus—Dermatitis—Quinidine—malaria	0.000231	0.00148	CcSEcCtD
Temsirolimus—Dermatitis—Quinine—malaria	0.000231	0.00148	CcSEcCtD
Temsirolimus—Headache—Quinidine—malaria	0.00023	0.00147	CcSEcCtD
Temsirolimus—Headache—Quinine—malaria	0.00023	0.00147	CcSEcCtD
Temsirolimus—Nausea—Dapsone—malaria	0.00023	0.00147	CcSEcCtD
Temsirolimus—Diarrhoea—Quinidine barbiturate—malaria	0.000227	0.00145	CcSEcCtD
Temsirolimus—Diarrhoea—Pentoxifylline—malaria	0.000226	0.00145	CcSEcCtD
Temsirolimus—MTOR—Signaling by Insulin receptor—TLR9—malaria	0.000224	0.0144	CbGpPWpGaD
Temsirolimus—Nausea—Clindamycin—malaria	0.000222	0.00142	CcSEcCtD
Temsirolimus—Dizziness—Quinidine barbiturate—malaria	0.000219	0.0014	CcSEcCtD
Temsirolimus—Dizziness—Pentoxifylline—malaria	0.000219	0.0014	CcSEcCtD
Temsirolimus—Nausea—Quinidine—malaria	0.000218	0.00139	CcSEcCtD
Temsirolimus—Nausea—Quinine—malaria	0.000218	0.00139	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000213	0.0137	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—IFNG—malaria	0.000213	0.0137	CbGpPWpGaD
Temsirolimus—Vomiting—Quinidine barbiturate—malaria	0.000211	0.00135	CcSEcCtD
Temsirolimus—Vomiting—Pentoxifylline—malaria	0.00021	0.00134	CcSEcCtD
Temsirolimus—Rash—Quinidine barbiturate—malaria	0.000209	0.00134	CcSEcCtD
Temsirolimus—Dermatitis—Quinidine barbiturate—malaria	0.000209	0.00133	CcSEcCtD
Temsirolimus—Rash—Pentoxifylline—malaria	0.000209	0.00133	CcSEcCtD
Temsirolimus—Dermatitis—Pentoxifylline—malaria	0.000208	0.00133	CcSEcCtD
Temsirolimus—Headache—Quinidine barbiturate—malaria	0.000208	0.00133	CcSEcCtD
Temsirolimus—Headache—Pentoxifylline—malaria	0.000207	0.00132	CcSEcCtD
Temsirolimus—Nausea—Quinidine barbiturate—malaria	0.000197	0.00126	CcSEcCtD
Temsirolimus—Nausea—Pentoxifylline—malaria	0.000196	0.00126	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL4—malaria	0.000189	0.0121	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL18—malaria	0.000188	0.0121	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD8A—malaria	0.000185	0.0119	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL10—malaria	0.000182	0.0117	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—CD40LG—malaria	0.000182	0.0117	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL4—malaria	0.000182	0.0117	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL4—malaria	0.000177	0.0114	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—TNF—malaria	0.000159	0.0102	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TLR4—malaria	0.000156	0.01	CbGpPWpGaD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—malaria	0.000155	0.00997	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—ICAM1—malaria	0.00015	0.00962	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—NOS2—malaria	0.000149	0.00955	CbGpPWpGaD
Temsirolimus—MTOR—IL2 signaling events mediated by PI3K—IL2—malaria	0.000144	0.00926	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IFNG—malaria	0.000144	0.00924	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—NOS2—malaria	0.000144	0.00922	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—malaria	0.000138	0.00886	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IL1B—malaria	0.000128	0.00824	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000118	0.00759	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IFNG—malaria	0.000114	0.00732	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IFNG—malaria	0.00011	0.00708	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD4—malaria	0.000106	0.00683	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—HPGDS—malaria	0.000103	0.00662	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL1B—malaria	0.000102	0.00653	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL2—malaria	0.000101	0.00651	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IFNG—malaria	9.96e-05	0.0064	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL1B—malaria	9.82e-05	0.00631	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL2—malaria	9.79e-05	0.00629	CbGpPWpGaD
Temsirolimus—MTOR—Costimulation by the CD28 family—CD4—malaria	9.62e-05	0.00618	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—KDR—malaria	9.5e-05	0.00611	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—KDR—malaria	8.97e-05	0.00576	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IL2—malaria	8.85e-05	0.00569	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL12B—malaria	8.85e-05	0.00568	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FCGR2B—malaria	8.45e-05	0.00543	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—IL1B—malaria	8.22e-05	0.00528	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CD4—malaria	8.13e-05	0.00522	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TIRAP—malaria	7.84e-05	0.00504	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TNF—malaria	7.64e-05	0.00491	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HLA-B—malaria	7.5e-05	0.00482	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—HPGDS—malaria	7.45e-05	0.00478	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TNF—malaria	7.38e-05	0.00474	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CR1—malaria	7.29e-05	0.00469	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—malaria	7.04e-05	0.00452	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—IL6—malaria	6.99e-05	0.00449	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PKLR—malaria	6.97e-05	0.00448	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL10—malaria	6.47e-05	0.00416	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CD40LG—malaria	6.47e-05	0.00416	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL4—malaria	6.29e-05	0.00404	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—malaria	6.28e-05	0.00403	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—G6PD—malaria	6.21e-05	0.00399	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR9—malaria	6.2e-05	0.00398	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—HLA-B—malaria	6.15e-05	0.00395	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL6—malaria	5.95e-05	0.00382	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—FAS—malaria	5.8e-05	0.00373	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	5.73e-05	0.00368	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	5.45e-05	0.0035	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CISH—malaria	5.43e-05	0.00349	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—HPGDS—malaria	5.3e-05	0.0034	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	5.17e-05	0.00332	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ACKR1—malaria	5.15e-05	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR2B—malaria	5.13e-05	0.00329	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.02e-05	0.00322	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FCGR2A—malaria	4.96e-05	0.00318	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TIRAP—malaria	4.57e-05	0.00294	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—DHFR—malaria	4.4e-05	0.00282	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—malaria	4.35e-05	0.0028	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CR1—malaria	4.25e-05	0.00273	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—malaria	4.23e-05	0.00272	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—malaria	4.2e-05	0.0027	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TLR9—malaria	4.15e-05	0.00267	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—malaria	4.09e-05	0.00263	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—malaria	4.09e-05	0.00263	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DHODH—malaria	4.02e-05	0.00258	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	3.98e-05	0.00256	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PKLR—malaria	3.92e-05	0.00252	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—malaria	3.8e-05	0.00244	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—malaria	3.68e-05	0.00236	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—malaria	3.62e-05	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR9—malaria	3.61e-05	0.00232	CbGpPWpGaD
Temsirolimus—MTOR—Disease—G6PD—malaria	3.5e-05	0.00225	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—HPGDS—malaria	3.46e-05	0.00222	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC4A1—malaria	3.42e-05	0.0022	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—malaria	3.42e-05	0.0022	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—malaria	3.39e-05	0.00218	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—malaria	3.39e-05	0.00218	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—malaria	3.38e-05	0.00217	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DECR1—malaria	3.22e-05	0.00207	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—malaria	2.94e-05	0.00189	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HLA-B—malaria	2.91e-05	0.00187	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HBB—malaria	2.91e-05	0.00187	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—malaria	2.91e-05	0.00187	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DHODH—malaria	2.91e-05	0.00187	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—malaria	2.9e-05	0.00187	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ACKR1—malaria	2.9e-05	0.00186	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR2A—malaria	2.89e-05	0.00185	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.86e-05	0.00184	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD36—malaria	2.86e-05	0.00183	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-B—malaria	2.8e-05	0.0018	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—malaria	2.78e-05	0.00178	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD36—malaria	2.74e-05	0.00176	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—malaria	2.73e-05	0.00176	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—malaria	2.61e-05	0.00168	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—malaria	2.6e-05	0.00167	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PKLR—malaria	2.59e-05	0.00167	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—malaria	2.59e-05	0.00166	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—malaria	2.57e-05	0.00165	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—malaria	2.57e-05	0.00165	CbGpPWpGaD
Temsirolimus—MTOR—Disease—DHFR—malaria	2.47e-05	0.00159	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC4A1—malaria	2.47e-05	0.00159	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—malaria	2.47e-05	0.00159	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—malaria	2.46e-05	0.00158	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—malaria	2.42e-05	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—malaria	2.42e-05	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.42e-05	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—malaria	2.4e-05	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—malaria	2.38e-05	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—malaria	2.37e-05	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TLR9—malaria	2.33e-05	0.0015	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DECR1—malaria	2.32e-05	0.00149	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—G6PD—malaria	2.31e-05	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ICAM1—malaria	2.27e-05	0.00146	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—malaria	2.24e-05	0.00144	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DHODH—malaria	2.19e-05	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.14e-05	0.00138	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HBB—malaria	2.1e-05	0.00135	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DHODH—malaria	2.07e-05	0.00133	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PKLR—malaria	1.87e-05	0.0012	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC4A1—malaria	1.87e-05	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—malaria	1.79e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—malaria	1.78e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—malaria	1.76e-05	0.00113	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HPGDS—malaria	1.76e-05	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—malaria	1.76e-05	0.00113	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC4A1—malaria	1.76e-05	0.00113	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DECR1—malaria	1.75e-05	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—malaria	1.74e-05	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-B—malaria	1.7e-05	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—malaria	1.67e-05	0.00107	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—G6PD—malaria	1.67e-05	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD36—malaria	1.66e-05	0.00107	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—malaria	1.66e-05	0.00107	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DECR1—malaria	1.65e-05	0.00106	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KDR—malaria	1.65e-05	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—malaria	1.65e-05	0.00106	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DHFR—malaria	1.63e-05	0.00105	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SCARB1—malaria	1.62e-05	0.00104	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HBB—malaria	1.59e-05	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—malaria	1.5e-05	0.000963	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HBB—malaria	1.49e-05	0.00096	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—malaria	1.44e-05	0.000924	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PKLR—malaria	1.41e-05	0.000908	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICAM1—malaria	1.38e-05	0.000886	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DHODH—malaria	1.35e-05	0.000868	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PKLR—malaria	1.33e-05	0.000856	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HPGDS—malaria	1.27e-05	0.000818	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—malaria	1.26e-05	0.000811	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—G6PD—malaria	1.26e-05	0.00081	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.22e-05	0.000781	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—G6PD—malaria	1.19e-05	0.000763	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DHFR—malaria	1.18e-05	0.000759	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SCARB1—malaria	1.17e-05	0.000751	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC4A1—malaria	1.15e-05	0.000738	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DECR1—malaria	1.08e-05	0.000694	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—malaria	1.07e-05	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—malaria	1.05e-05	0.000674	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CD36—malaria	1.02e-05	0.000652	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—malaria	1.01e-05	0.000651	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HBB—malaria	9.77e-06	0.000628	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HPGDS—malaria	9.61e-06	0.000617	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—malaria	9.41e-06	0.000604	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—malaria	9.36e-06	0.000601	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—malaria	9.35e-06	0.000601	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—malaria	9.32e-06	0.000599	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KDR—malaria	9.3e-06	0.000597	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HPGDS—malaria	9.06e-06	0.000582	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—malaria	8.99e-06	0.000578	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DHFR—malaria	8.92e-06	0.000573	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SCARB1—malaria	8.82e-06	0.000567	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PKLR—malaria	8.71e-06	0.00056	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DHFR—malaria	8.4e-06	0.00054	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SCARB1—malaria	8.31e-06	0.000534	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—G6PD—malaria	7.76e-06	0.000499	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD36—malaria	7.34e-06	0.000471	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—malaria	6.3e-06	0.000405	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—malaria	6.03e-06	0.000387	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HPGDS—malaria	5.92e-06	0.00038	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD36—malaria	5.54e-06	0.000356	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DHFR—malaria	5.49e-06	0.000353	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—malaria	5.48e-06	0.000352	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SCARB1—malaria	5.44e-06	0.000349	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD36—malaria	5.22e-06	0.000335	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—malaria	5.06e-06	0.000325	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—malaria	3.54e-06	0.000228	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD36—malaria	3.41e-06	0.000219	CbGpPWpGaD
